These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8882302)

  • 1. Drug monitoring in nonconventional biological fluids and matrices.
    Pichini S; Altieri I; Zuccaro P; Pacifici R
    Clin Pharmacokinet; 1996 Mar; 30(3):211-28. PubMed ID: 8882302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate Matrices: Meconium, Cord Tissue, Hair, and Oral Fluid.
    Palmer KL; Krasowski MD
    Methods Mol Biol; 2019; 1872():191-197. PubMed ID: 30350291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological matrices for the evaluation of in utero exposure to drugs of abuse.
    Lozano J; García-Algar O; Vall O; de la Torre R; Scaravelli G; Pichini S
    Ther Drug Monit; 2007 Dec; 29(6):711-34. PubMed ID: 18043469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological sample collection for clinical proteomics: existing SOPs.
    Lygirou V; Makridakis M; Vlahou A
    Methods Mol Biol; 2015; 1243():3-27. PubMed ID: 25384737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalytical procedures for monitoring in utero drug exposure.
    Gray T; Huestis M
    Anal Bioanal Chem; 2007 Aug; 388(7):1455-65. PubMed ID: 17370066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some more about dogs: Proteomics of neglected biological fluids.
    Miller I; Schlosser S; Palazzolo L; Veronesi MC; Eberini I; Gianazza E
    J Proteomics; 2020 Apr; 218():103724. PubMed ID: 32126321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring in Neonates: What Makes them Unique?
    Mian P; Flint RB; Tibboel D; van den Anker JN; Allegaert K; Koch BCP
    Curr Pharm Des; 2017; 23(38):5790-5800. PubMed ID: 28950825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs in nails: physiology, pharmacokinetics and forensic toxicology.
    Palmeri A; Pichini S; Pacifici R; Zuccaro P; Lopez A
    Clin Pharmacokinet; 2000 Feb; 38(2):95-110. PubMed ID: 10709775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants.
    Liu H; Delgado MR
    Clin Pharmacokinet; 1999 Jun; 36(6):453-70. PubMed ID: 10427469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.
    de la Torre R; Farré M; Navarro M; Pacifici R; Zuccaro P; Pichini S
    Clin Pharmacokinet; 2004; 43(3):157-85. PubMed ID: 14871155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of noninvasive biomatrices in pharmacokinetic studies.
    Raju KS; Taneja I; Singh SP; Wahajuddin
    Biomed Chromatogr; 2013 Oct; 27(10):1354-66. PubMed ID: 23939915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic process: does the site of drug action? Excretion of drugs].
    Carrillo Norte JA
    Rev Enferm; 2011 Sep; 34(9):24-31. PubMed ID: 22013710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment.
    Lien EA; Solheim E; Lea OA; Lundgren S; Kvinnsland S; Ueland PM
    Cancer Res; 1989 Apr; 49(8):2175-83. PubMed ID: 2702659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting.
    Gargosky SE; Pham HM; Wilson KF; Liu F; Giudice LC; Rosenfeld RG
    Endocrinology; 1992 Dec; 131(6):3051-60. PubMed ID: 1280211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological matrices for the evaluation of exposure to environmental tobacco smoke during prenatal life and childhood.
    Llaquet H; Pichini S; Joya X; Papaseit E; Vall O; Klein J; Garcia-Algar O
    Anal Bioanal Chem; 2010 Jan; 396(1):379-99. PubMed ID: 19466395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure.
    Ritschel WA; Tompson GA
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):511-25. PubMed ID: 6363838
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of Postmortem Drug Concentrations in Bile Compared with Blood and Urine in Forensic Autopsy Cases.
    Tominaga M; Michiue T; Oritani S; Ishikawa T; Maeda H
    J Anal Toxicol; 2016 Jun; 40(5):367-73. PubMed ID: 27185819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring.
    Abanades S; Farré M; Segura M; Pichini S; Pastor A; Pacifici R; Pellegrini M; de la Torre R
    Ther Drug Monit; 2007 Feb; 29(1):64-70. PubMed ID: 17304152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the acidification of hydrophilic matrices on the liberation of poorly soluble drugs in intestinal fluid].
    Ventouras K; Buri P
    Pharm Acta Helv; 1978; 53(11):314-20. PubMed ID: 34171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.